Sitagliptin added to voglibose monotherapy improves glycemic control in patients with type 2 diabetes

Documenti analoghi

• Addition of sitagliptin to ongoing metformin monotherapy improves glycemic control in Japanese patients with type 2 diabetes over 52 weeks
  di: Kadowaki, Takashi, et al.
  Pubblicazione: (2012)
• Safety and efficacy of addition of sitagliptin to rapid-acting insulin secretagogues for glycemic control, including post-prandial hyperglycemia, among Japanese with type 2 diabetes mellitus
  di: Tajima, Naoko, et al.
  Pubblicazione: (2015)
• Sitagliptin added to treatment with ongoing pioglitazone for up to 52 weeks improves glycemic control in Japanese patients with type 2 diabetes
  di: Kashiwagi, Atsunori, et al.
  Pubblicazione: (2011)
• Factors associated with the glucose‐lowering efficacy of sitagliptin in Japanese patients with type 2 diabetes mellitus: Pooled analysis of Japanese clinical trials
  di: Tajima, Naoko, et al.
  Pubblicazione: (2019)
• A Randomized, Placebo-Controlled Trial Evaluating the Safety and Efficacy of Adding Omarigliptin to Antihyperglycemic Therapies in Japanese Patients with Type 2 Diabetes and Inadequate Glycemic Control
  di: Gantz, Ira, et al.
  Pubblicazione: (2017)